Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries

被引:0
作者
Z. Wang
M. M. Ward
L. Chan
T. Bhattacharyya
机构
[1] National Institutes of Health,Intramural Research Program, National Institute of Arthritis, Musculoskeletal and Skin Diseases
[2] National Institutes of Health,Department of Rehabilitation Medicine, the Clinical Center
来源
Osteoporosis International | 2014年 / 25卷
关键词
Bisphosphonates; Fracture; Osteoporosis; Atypical femur fracture;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2109 / 2116
页数:7
相关论文
共 50 条
[41]   Reduced Risk of Reoperation Using Intramedullary Nailing with Femoral Neck Protection in Low-Energy Femoral Shaft Fractures [J].
Bogl, Hans Peter ;
Zdolsek, Georg ;
Michaelsson, Karl ;
Hoijer, Jonas ;
Schilcher, Jorg .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (17) :1486-1494
[42]   Oral anticoagulants and the risk of osteoporotic fractures among elderly [J].
Pilon, D ;
Castilloux, AM ;
Dorais, M ;
LeLorier, J .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (05) :289-294
[43]   Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice [J].
T. Thomas ;
S. Horlait ;
J. D. Ringe ;
A. Abelson ;
D. T. Gold ;
P. Atlan ;
J. L. Lange .
Osteoporosis International, 2013, 24 :263-269
[44]   Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice [J].
Thomas, T. ;
Horlait, S. ;
Ringe, J. D. ;
Abelson, A. ;
Gold, D. T. ;
Atlan, P. ;
Lange, J. L. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) :263-269
[45]   Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data [J].
Shalev, Varda ;
Moser, Sarah Sharman ;
Goldshtein, Inbal ;
Yu, Jingbo ;
Weil, Clara ;
Ish-Shalom, Sophia ;
Rouach, Vanessa ;
Chodick, Gabriel .
ANNALS OF PHARMACOTHERAPY, 2017, 51 (09) :757-767
[46]   GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates [J].
P. Hadji ;
V. Claus ;
V. Ziller ;
M. Intorcia ;
K. Kostev ;
T. Steinle .
Osteoporosis International, 2012, 23 :223-231
[47]   GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates [J].
Hadji, P. ;
Claus, V. ;
Ziller, V. ;
Intorcia, M. ;
Kostev, K. ;
Steinle, T. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) :223-231
[48]   Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy [J].
Franceschetti, Paola ;
Bondanelli, Marta ;
Caruso, Gaetano ;
Ambrosio, Maria Rosaria ;
Lorusso, Vincenzo ;
Zatelli, Maria Chiara ;
Massari, Leo ;
degli Uberti, Ettore C. .
BONE, 2013, 56 (02) :426-431
[49]   Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population [J].
A. Keshishian ;
N. Boytsov ;
R. Burge ;
K. Krohn ;
L. Lombard ;
X. Zhang ;
L. Xie ;
O. Baser .
Osteoporosis International, 2017, 28 :2485-2494
[50]   Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population [J].
Keshishian, A. ;
Boytsov, N. ;
Burge, R. ;
Krohn, K. ;
Lombard, L. ;
Zhang, X. ;
Xie, L. ;
Baser, O. .
OSTEOPOROSIS INTERNATIONAL, 2017, 28 (08) :2485-2494